Region: United States
Category: Life Sciences

United States Life Sciences

(3,969 reports matching your criteria)
  • Telehealth Services in the US - Industry Market Research Report

    ... in March 2020 in response to federal mandates and health concerns. Born out of necessity, widespread telehealth adoption in 2020 was crucial during the pandemic; at its peak, the number of telehealth visits increased 154.0% ... Read More

  • Pharmaceutical Contract Management Consulting in the US - Industry Market Research Report

    ... patents on blockbuster drugs, has stimulated the volume of research and development (R&D) work outsourced by generic pharmaceutical and biotechnology companies, promoting growth for consultants. The outbreak of COVID-19 led to growth for consultants as ... Read More

  • Laboratory Testing Services in the US - Industry Market Research Report

    ... ranging from consumer and food products to industrial materials. As consumer goods become increasingly regulated, increased demand for testing services continues. Over the past five years, testing services providers have experienced growth in demand for ... Read More

  • Nursing Care Facilities in the US - Industry Market Research Report

    ... five years. Revenue has fluctuated during the outbreak and recovery period of the COVID-19 pandemic, which spurred a need for industry services. The number of adults aged 65 and older has been increasing consistently for ... Read More

  • Dental Clinical Instrument Manufacturing in the US - Industry Market Research Report

    ... demand for routine dental procedures and the growing number of Americans over the age of 65. Recent disruptions to the international market for US-made dental instruments have led to a significant decline in the value ... Read More

  • Medical & Recreational Marijuana Stores in the US - Industry Market Research Report

    ... (by prescription only) and recreational marijuana, has expanded dramatically over the past five years. The legalization of marijuana for medical and/or recreational purposes and the growing acceptance of legal marijuana use provided operators and investors ... Read More

  • Home Health Care Services

    ... homes. Major companies include Amedisys, Apria, CenterWell Home Health, and Lincare (all based in the US), along with Cera Care (UK), LVL Médical (France), and SE Health (Canada). COMPETITIVE LANDSCAPE Health reform efforts are driving ... Read More

  • Fibrin Sealants

    ... at a CAGR of 6.0% over the analysis period 2023-2030. Liquid Sealants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.2 Billion by the end of ... Read More

  • Blood Transfusion Diagnostics

    ... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$1.7 ... Read More

  • Exosome Research Products

    ... by 2030, growing at a CAGR of 20.6% over the analysis period 2023-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$697.8 Million ... Read More

  • Microelectronic Medical Implants

    ... by 2030, growing at a CAGR of 8.2% over the analysis period 2023-2030. Pacemakers & Defibrillators, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$20.6 Billion ... Read More

  • Produce Packaging Trays

    ... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Growers / Shippers End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.0 ... Read More

  • Therapeutic Respiratory Devices

    ... by 2030, growing at a CAGR of 3.4% over the analysis period 2023-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$32.3 ... Read More

  • Office Administrative Services

    ... by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Administrative Management Services, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$62.1 Billion ... Read More

  • Prostate Cancer Diagnostics

    ... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More

  • Tissue Engineering

    ... at a CAGR of 12.5% over the analysis period 2023-2030. Orthopedics, Musculoskeletal & Spine Application, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.7 Billion by ... Read More

  • Surgical Sealants and Adhesives

    ... reach US$5.5 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Natural Sealants and Adhesives, one of the segments analyzed in the report, is expected to record a 6.7% CAGR ... Read More

  • Counter Terror and Public Safety Technology

    ... the year 2023, is expected to reach US$532.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2023-2030. Cyber Security Technology, one of the segments analyzed in the report, is expected ... Read More

  • Flea and Tick Products

    ... reach US$11.2 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Chewable Products, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach ... Read More

  • Plant Cell Culture Equipment

    ... reach US$2.6 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Centrifuges, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$784.8 ... Read More

  • Insulin Pens

    ... at a CAGR of 7.1% over the analysis period 2023-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$11.6 Billion by the end ... Read More

  • Antisense and RNAi Therapeutics

    ... reach US$3.6 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Antisense RNA Technology, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More

  • Vancomycin

    ... of 4.9% over the analysis period 2023-2030. Lung Infection Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis ... Read More

  • Nail Care

    ... at a CAGR of 2.5% over the analysis period 2023-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$8.3 Billion by the end of ... Read More

  • Veterinary X-ray

    ... at a CAGR of 6.4% over the analysis period 2023-2030. Computed Radiography Technology, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$360.6 Million by the end ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings